NCT00757978View on ClinicalTrials.gov

Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms

PHASE4CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

March 31, 2008

Conditions
Schizophrenia
Interventions
DRUG

memantine

memantine 10mg twice a day

DRUG

placebo

1 capsule of placebo twice a day

Trial Locations (1)

90035-903

Hospital de Clinicas de Porto Alegre, Porto Alegre

All Listed Sponsors
lead

Hospital de Clinicas de Porto Alegre

OTHER

NCT00757978 - Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms | Biotech Hunter | Biotech Hunter